(19)
(11) EP 3 952 840 A1

(12)

(43) Date of publication:
16.02.2022 Bulletin 2022/07

(21) Application number: 19924315.5

(22) Date of filing: 12.04.2019
(51) International Patent Classification (IPC): 
A61K 9/08(2006.01)
A61K 9/14(2006.01)
A61K 9/48(2006.01)
A61K 31/55(2006.01)
A61K 47/00(2006.01)
 A61K 9/10(2006.01)
A61K 9/20(2006.01)
A61K 31/13(2006.01)
A61K 31/495(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/13; A61K 31/55; A61K 9/20; A61K 9/48; A61P 25/28
 
C-Sets:
  1. A61K 31/55, A61K 2300/00;
  2. A61K 31/13, A61K 2300/00;
(86) International application number:
PCT/US2019/027293
(87) International publication number:
WO 2020/209872 (15.10.2020 Gazette 2020/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicants:
  • La Pharma Tech Inc.
    Blacksburg, VA 24060 (US)
  • Wang, Jianmin
    Blacksburg, VA 24060 (US)
  • Cui, Geping
    Blackburg, VA 24060 (US)

(72) Inventors:
  • WANG, Jianmin
    Blacksburg, VA 24060 (US)
  • CUI, Geping
    Blacksburg, VA 24060 (US)

(74) Representative: Witthoff Jaekel Steinecke Patentanwälte PartG mbB 
Postfach 1140
52412 Jülich
52412 Jülich (DE)

   


(54) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING MENTAL, BEHAVIORAL, COGNITIVE DISORDERS